Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 1029-1035

  Nillius, Dorothea ^a   Müller, Joachim ^a   Müller, Norbert ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Drug susceptibility; Stable expression; Transfection

Indexed keywords

GIARDIA LAMBLIA NITROREDUCTASE 1; METRONIDAZOLE; NITAZOXANIDE; NITROREDUCTASE; UNCLASSIFIED DRUG;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; ESCHERICHIA COLI; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GIARDIA LAMBLIA; NONHUMAN; NUCLEOTIDE SEQUENCE; WESTERN BLOTTING;

ANTI-INFECTIVE AGENTS; ESCHERICHIA COLI; GIARDIA LAMBLIA; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; NITRO COMPOUNDS; NITROREDUCTASES; OXIDATION-REDUCTION; PARASITIC SENSITIVITY TESTS; THIAZOLES;

EID: 79954583944     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr029     Document Type: Article

References (32)

1. Upcroft J, Upcroft P. My favourite cell: Giardia. BioEssays 1998; 20: 256-63.
2. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev 2001; 14: 114-28.
3. Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001; 14: 150-64.
4. Mørch K, Hanevik K, Robertson LJ et al. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. J Infect 2008; 56: 268-73.
5. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005; 40: 1173-80.
6. Hemphill A, Müller J, Esposito M. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 2006; 7: 953-64.
7. Townson SM, Upcroft JA, Upcroft P. Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. Mol Biochem Parasitol 1996; 79: 183-93.
8. Pal D, Banerjee S, Cui J et al. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases). Antimicrob Agents Chemother 2009; 53: 458-64.
9. Ballard TE, Wang X, Olekhnovich I et al. Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide. Bioorg Med Chem Lett 2010; 20: 3537-9.
10. Hoffman PS, Sisson G, Croxen MA et al. Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Agents Chemother 2007; 51: 868-76.
11. Müller J, Wastling J, Sanderson S et al. A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrob Agents Chemother 2007; 51: 1979-86.
12. Müller J, Sterk M, Hemphill A et al. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother 2007; 60: 280-7.
13. Moreno SN, Docampo R. Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis. Environ Health Perspect 1985; 64: 199-208.
14. Adagu IS, Nolder D, Warhurst D et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J Antimicrob Chemother 2002; 49: 103-11.
15. Keister DB. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans R Soc Trop Med Hyg 1983; 77: 487-8.
16. Müller J, Nillius D, Hehl A et al. Stable expression of Escherichia coli β-glucuronidase A (GusA) in Giardia lamblia: application to high-throughput drug susceptibility testing. J Antimicrob Chemother 2009; 64: 1187-91.
17. Jimenez-Garci{dotless}a LF, Zavala G, Chavez-Mungui{dotless}a B et al. Identification of nucleoli in the early branching protist Giardia duodenalis. Int J Parasitol 2008; 38: 1297-304.
18. Davis-Hayman S, Nash TE. Genetic manipulation of Giardia lamblia. Mol Biochem Parasitol 2002; 122: 1-7.
19. Sonda S, Fuchs N, Gottstein B et al. Molecular characterisation of a novel microneme antigen in Neospora caninum. Mol Biochem Parasitol 2000; 108: 39-51.
20. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
21. Bénéré E, da Luz RAI, Vermeersch M et al. A new quantitative in vitro microculture method for Giardia duodenalis trophozoites. J Microbiol Methods 2007; 71: 101-6.
22. DeCross AJ, Marshall BJ, McCallum RW et al. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol 1993; 31: 1971-4.
23. Mishra KK, Srivastava S, Garg A et al. Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods. Curr Microbiol 2006; 53: 329-34.
24. Olekhnovich IN, Goodwin A, Hoffman PS. Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori. FEBS J 2009; 276: 3354-64.
25. Wittwer CT, Ririe KM, Andrew RV et al. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997; 22: 176-81.
26. Valdez CA, Tripp JC, Miyamoto Y et al. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia. J Med Chem 2009; 52: 4038-53.
27. Kutty R, Bennett GN. Biochemical characterization of trinitrotoluene transforming oxygen-insensitive nitroreductases from Clostridium acetobutylicum ATCC 824. Arch Microbiol 2005; 184: 158-67.
28. Dunn LA, Burgess AG, Krauer KG et al. A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro. Int J Antimicrob Agents 2010; 36: 37-42.
29. Bailey SM, Knox RJ, Hobbs SM et al. Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy. Gene Therapy 1996; 3: 1143-50.
30. Verdijk RM, Wilke M, Beslier V et al. Escherichia coli-nitroreductase suicide gene control of human telomerase reverse transcriptasetransduced minor histocompatibility antigen-specific cytotoxic T cells. Bone Marrow Transplant 2004; 33: 963-7.
31. Zenno S, Koike H, Kumar AN et al. Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. J Bacteriol 1996; 178: 4506-14.
32. Müller J, Ley S, Felger I et al. Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J Antimicrob Chemother 2008; 62: 72-82.